Investor Relations

For information on how to invest, please contact Gary Grieco at ggrieco@para-con.com For information about Rule 144 Securities, please click here. This PDF document contains the following:

The attached September 28, 2017 letter from our President (page 1);
The SEC’s most recent publication on this topic (page 2 – 4); and
The attached, required questionnaire from Standard Registrar & Transfer Company Inc. (Bingham Canyon Corporations’ transfer agent) (pages 5 – 7).

Investor Relations Firm

Tim Rieu, CEO
Chesapeake Group

Strategic Investor Relations Management
305 Washington Avenue, Suite 100
Towson, MD 21204

For OTC Markets Information

Go to OTC Markets Group for:

Overview
Quote
Company Profile
Security Details

News
Financials
Disclosure
Research

Company News

PCT LTD Announces Completion of Major Commercialization Milestones and Promotion of Jody Read to CEO Position

November 8, 2018

PCT LTD (OTC Pink: PCTL), a leader in environmentally safe, non-toxic, antimicrobial solutions for global sustainability, has reached significant company milestones through its wholly-owned operating

PCT Ltd Secures Contract for 2 Annihilyzer® Hospital Infection Control Systems in Brooklyn Hospital

November 1, 2018

PCT LTD’s operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announced today that, with its New York-based representative, it has entered into a contractual agreement

PCT Ltd enters into Master Services Agreement for Installation of Annihilyzer® Infection Control Systems in the Greater New York Area

October 26, 2018

PCT LTD’s operating subsidiary, Paradigm Convergence Technologies Corporation (PCT Corp), announced today it has entered into a Master Services Agreement with a New York-based hospital